The LW blood group system: not just "tagging along" with D.
ICAM4
LW
blood group system
Journal
Immunohematology
ISSN: 0894-203X
Titre abrégé: Immunohematology
Pays: United States
ID NLM: 8806387
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
medline:
7
7
2023
pubmed:
5
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
This update of the Landsteiner-Wiener (LW) blood group system (Grandstaff Moulds MK. The LW blood group system: a review. Immunohematology 2011;27:136-42. Storry JR. Review: the LW blood group system. Immunohematology 1992;8:87-93) reports new information on the distribution of genetic variants in ICAM4 and reviews the complex serologic identification of the high-prevalence LWEM antigen. The role of ICAM4 in sickle cell disease and malaria susceptibility is discussed.
Identifiants
pubmed: 37405848
pii: immunohematology-2023-012
doi: 10.21307/immunohematology-2023-012
doi:
Substances chimiques
Blood Group Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
72-76Informations de copyright
© 2023 E.C. McGowan et al., published by Sciendo.
Références
Gahmberg CG, Valmu L, Kotovuori A, et al. Leukocyte adhesion: an integrated molecular process at the leukocyte plasma membrane. Biosci Rep 1999;19:273–81.
Hermand P, Gane P, Callebaut I, Kieffer N, Cartron J-P, Bailly P. Integrin receptor specificity for human red cell ICAM-4 ligand. Eur J Biochem 2004;271:3729–40.
Lee G, Lo A, Short SA, et al. Targeted gene deletion demonstrates that the cell adhesion molecule ICAM-4 is critical for erythroblastic island formation. Blood 2006;108:2064–71.
Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated αIIbβ3 integrin. J Biol Chem 2003;278:4892–8.
Ihanus E, Uotila LM, Toivanen A, Varis M, Gahmberg CG. Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4. Blood 2006;109:802–10.
Levine P, Celano MJ, Wallace J, Sanger R. A human ‘D-like’ antibody. Nature 1963;198:596–7.
Hermand P, Le Pennec PY, Rouger P, Cartron JP, Bailly P. Characterization of the gene encoding the human LW blood group protein in LW+ and LW– phenotypes. Blood 1996;87:2962–7.
Hermand P, Gane P, Mattei MG, Sistonen P, Cartron JP, Bailly P. Molecular basis and expression of the LWa/LWb blood group polymorphism. Blood 1995;86:1590–4.
Sistonen P, Virtaranta-Knowles K, Denisova R, Kucinskas V, Ambrasiene D, Beckman L. The LWb blood group as a marker of prehistoric Baltic migrations and admixture. Hum Hered 1999;49:154–8.
Srivastava K, Almarry NS, Flegel WA. Genetic variation of the whole ICAM4 gene in Caucasians and African Americans. Transfusion 2014;54:2315–24.
Yin Q, Srivastava K, Schneider JB, Gebremedhin A, Makuria AT, Flegel WA. Molecular analysis of the ICAM4 gene in an autochthonous East African population. Transfusion 2019;59:1880–1.
Lopez GH, Wilson B, Millard GM, et al. A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LW*A c.309C>A variant. Vox Sang 2022;117:958–65.
Gauthier E, Kappler-Gratias S, Vallet D, et al. LW null phenotype: identification of two novel mutations in the LW gene. AABB Abstracts 2012;158A.
Grandstaff Moulds MK. The LW blood group system: a review. Immunohematology 2011; 27:136–42.
Storry JR. Review: the LW blood group system. Immunohematology 1992;8:87–93.
Sistonen P, Tippett P. A ‘new’ allele giving further insight into the LW blood group system. Vox Sang 1982;42:252–5.
Gibbs MB. The quantitative relationship of the Rh-like (LW) and D antigens of human erythrocytes. Nature 1966;210: 642–3.
Merron BM, Maguire K, Morris K. When is an anti-D antibody not an anti-D antibody? Transfus Med 2015;25:115–7.
Miola MP, Cervo SV, Fachini RM, Ricci Júnior O. Do not confuse anti-LW autoantibodies with anti-D. Rev Bras Hematol Hemoter 2013;35:198.
Konigshaus GJ, Holland TI. The effect of dithiothreitol on the LW antigen. Transfusion 1984;24:536–7.
Bailly P, Hermand P, Callebaut I, et al. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci U S A 1994;91:5306–10.
Fraser NS, Knauth CM, Schoeman EM, et al. Investigation of the variable In(Lu) phenotype caused by KLF1 variants. Transfusion 2018;58:2414–20.
Zhang J, Abiraman K, Jones SM, Lykotrafitis G, Andemariam B. Regulation of active ICAM-4 on normal and sickle cell disease RBCs via AKAPs is revealed by AFM. Biophys J 2017;112:143–52.
Zennadi R, Whalen EJ, Soderblom EJ, et al. Erythrocyte plasma membrane–bound ERK1/2 activation promotes ICAM-4–mediated sickle red cell adhesion to endothelium. Blood 2012;119:1217–27.
MacKinney A, Woska E, Spasojevic I, Batinic-Haberle I, Zennadi R. Disrupting the vicious cycle created by NOX activation in sickle erythrocytes exposed to hypoxia/reoxygenation prevents adhesion and vasoocclusion. Redox Biol 2019;25:101097.
McMahon TJ, Shan S, Riccio DA, et al. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo. Blood Adv 2019;3:2586–97.
Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007;104:17063–8.
Cowman AF, Tonkin CJ, Tham WH, Duraisingh MT. The molecular basis of erythrocyte invasion by malaria parasites. Cell Host Microbe 2017;22:232–45.
Bhalla K, Chugh M, Mehrotra S, et al. Host ICAMs play a role in cell invasion by Mycobacterium tuberculosis and Plasmodium falciparum . Nat Commun 2015;6:6049.